Seed funding plays a crucial role in the biotech startup ecosystem, providing early-stage companies with the capital needed to develop innovative technologies and therapies. According to Labiotech, seed funding rounds for biotech startups have shown significant activity in recent years. In 2024, there were multiple seed funding rounds across various months, with amounts ranging from a few million to tens of millions of dollars per round (Labiotech 2024 funding tracker).  

The biotech sector continues to attract substantial investment across different funding stages, with seed rounds being particularly important for launching new ventures in areas such as drug discovery, gene therapies, and AI-enabled biotechnology platforms.

Resolution Criteria:

This question will be resolved using Labiotech’s biotech funding tracker. Only investments categorized as "Seed round" under "Funding type" will be counted. You can enter "Seed round" in the search box above the table to see all of the seed funding raised for biotech startups. 

Labiotech’s funding tracker for 2024 is available here, and the 2025 tracker is available here. EU, UK, and Swiss startups raised roughly $380 million in seed round funding in 2024. As of 8 August 2025, EU, UK, and Swiss startups raised $119.3 million in seed funding in 2025. This question will be updated to include a link to the 2026 funding tracker when it becomes available.

Note: RFI admins will use the funding amount given in U.S. dollars wherever possible. If funding is listed in another currency without the amount in U.S. dollars, we will use the midmarket conversion rate listed on xe.com for the day the funding was announced, if known, or on the first day of the month if not.